Saniona: partner secures USD 40 million in a series B financing
Research Note
2018-11-15
21:37
Cadent Therapeutics, a partner company to Saniona, announced on Thursday that they had secured a USD 40 million financing to advance its pipeline. Lead candidate is CAD-1883, a compound discovered in a collaboration between Saniona and Cadent Therapeutics.
AH
Anders Hedlund
Disclosures and disclaimers